MOG (35-55), human – 1 mg

Overview

The MOG (35-55) peptide is a key fragment of the myelin oligodendrocyte glycoprotein, specifically amino acids 35 to 55. It plays a crucial role in research related to human multiple sclerosis, particularly in the context of inducing experimental autoimmune encephalomyelitis (EAE) models. This peptide is vital for scientists exploring the complexities of neurological diseases and understanding their underlying mechanisms.

Key Features

• Contains amino acids 35 to 55 of human myelin oligodendrocyte glycoprotein.
• Used to induce EAE in mouse and rat models.
• Essential for studies targeting human multiple sclerosis.
• High-purity grade for reliable and reproducible results.
• Supports advancements in neurological research.

Specifications

FAQ

What is the primary use of MOG (35-55)?

MOG (35-55) is primarily used to induce experimental autoimmune encephalomyelitis in mouse and rat models, serving as a crucial tool in multiple sclerosis research.

How is MOG (35-55) administered in experiments?

This peptide can be administered through various routes depending on the research protocol, often via injection in animal models to study immune responses.

Where can I find more peptides for my research?

You can explore our broad range of peptides in our catalog, including options like PKG Substrate and Autocamtide-2which are essential for various research applications.

Choosing the right peptide is critical for your research success. Invest in MOG (35-55) today to support your studies in multiple sclerosis and related neurological conditions. With its high purity and specific application, this peptide will be a valuable addition to your experimental toolkit.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.